作者：
Paré,G. [1]
;
Eriksson,N. [2]
;
Lehr,T. [3]
;
Connolly,S. [4]
;
Eikelboom,J. [5]
;
Ezekowitz,M.D. [6]
;
Axelsson,T. [7]
;
Haertter,S. [8]
;
Oldgren,J. ;
Reilly,P. ;
Siegbahn,A. ;
Syvanen,A.-C. ;
Wadelius,C. ;
Wadelius,M. ;
Zimdahl-Gelling,H. ;
Yusuf,S. ;
Wallentin,L.
作者单位：
Department of Medical Sciences, Uppsala University, Uppsala, Sweden
[1]
Thomas Jefferson Medical College, Cardiovascular Research Foundation, Philadelphia, PA, United
[2]
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University
[3]
Boehringer Ingelheim Pharma GmbH and Co KG, Biberach, Germany
[4]
Boehringer Ingelheim Pharma Inc., Ridgefield, CT, United States
[5]
Boehringer Ingelheim Pharma GmbH and Co KG, Biberach, Germany, Clinical Pharmacy, Saarland
[6]
Uppsala Clinical Research Center, Department of Medical Sciences, Uppsala University, Uppsala
[7]
Population Health Research Institute, Hamilton Health Sciences and McMaster University, David
[8]
发布时间
2013-11-20
换一批
